How Does Ivermectin Work? Mechanism of Action Explained in Plain English

Ivermectin is remarkable for a simple reason: it kills parasites efficiently while leaving human cells essentially unaffected. Understanding why requires a short trip into cell biology — but don't worry, we'll keep it in plain English. Here's how ivermectin works, why it's so selective for parasites, and why that selectivity is also why it's safe for humans at therapeutic doses.

The Target: A Channel That Parasites Have and Humans Don't Use the Same Way

Nerve cells communicate by sending electrical signals. These signals are controlled by channels — tiny protein gates in the cell membrane — that open and close to let charged particles (ions) flow in and out. Different channels respond to different chemical messengers.

Ivermectin targets a specific type of channel called a glutamate-gated chloride channel (GluCl channel). These channels are found in the nerve and muscle cells of invertebrates — worms, insects, and mites — and play a critical role in their neuromuscular function. When ivermectin binds to these channels, it forces them open permanently. Chloride ions flood in, the nerve cells become paralyzed, and the parasite loses muscle function and dies.

Why Is Ivermectin Safe for Humans?

Humans do have glutamate-gated receptors, but they are found primarily in the central nervous system (the brain and spinal cord) — which is protected by the blood-brain barrier. This barrier acts as a selective filter that prevents ivermectin from entering the brain in significant quantities.

A protein called P-glycoprotein (P-gp) plays a key role in this protection. P-glycoprotein actively pumps ivermectin back out of brain cells before it can accumulate. As a result, at normal therapeutic doses, ivermectin cannot reach meaningful concentrations in the human brain — so it can't affect the GluCl channels there.

Parasites don't have this same protection. Their GluCl channels are exposed in peripheral nerve and muscle tissue — exactly where ivermectin can reach easily. This is the key to ivermectin's remarkable therapeutic window: it kills parasites at doses that barely affect human cells.

The GABA Connection

In addition to glutamate-gated channels, ivermectin also affects GABA-gated chloride channels in parasites. GABA (gamma-aminobutyric acid) is a neurotransmitter — a chemical messenger — that normally helps regulate nerve signaling. Ivermectin enhances GABA activity at these channels in parasite nerve cells, causing even more chloride influx and electrical silence. The combined effect on both channel types is potent neuromuscular paralysis in the target organism.

How Quickly Does Ivermectin Work?

Ivermectin begins to act relatively quickly after oral absorption. The drug reaches peak blood concentrations within 4 hours of a dose. For onchocerciasis, clinical studies showed an 83% reduction in skin microfilariae count just 3 days after a single dose, with a 99.5% reduction at 3 months. For scabies, parasites begin dying within hours, though it may take 1-2 weeks for itching to fully resolve as the skin heals.

Why P-glycoprotein Matters for Drug Interactions

Because P-glycoprotein is the main reason ivermectin stays out of the human brain, drugs that inhibit P-gp can be dangerous when taken with ivermectin. If P-gp is blocked, ivermectin can accumulate in the central nervous system and cause neurological side effects — confusion, ataxia, seizures. This is why drugs like quinidine, ritonavir, and itraconazole warrant caution when combined with ivermectin.

For a full list of drug interactions that can affect ivermectin's safety, see our guide on ivermectin drug interactions.

Why Ivermectin Doesn't Work Against COVID-19

Ivermectin was shown in early lab studies to inhibit SARS-CoV-2 replication in cell cultures. This generated significant interest — and significant misinformation. The problem: achieving the plasma concentrations needed to inhibit the virus in human tissues would require doses estimated at 35-100 times the maximum FDA-approved dosage. At those levels, ivermectin would be poisonous. Clinical trials in humans — including large trials like TOGETHER, COVID-OUT, and ACTIV-6 — found no clinically meaningful benefit.

For a complete overview of ivermectin's approved uses and who it's for, read our article on what is ivermectin.